Home » Topics » Regulatory » Patents

Patents
RSS

Raze Therapeutics presents novel MTHFD2 inhibitors

Feb. 21, 2017

Vitae Pharmaceuticals discloses novel nuclear receptor ROR-gamma modulators

Feb. 21, 2017

Amgen discovers beta-secretase inhibitors

Feb. 21, 2017

Novel TNF-alpha antagonists synthesized at Bristol-Myers Squibb

Feb. 21, 2017

NantWorks/Nant Holdings patent thiosemicarbazone derivatives

Feb. 21, 2017

Samumed identifies novel Wnt signaling and IL-6 production inhibitors

Feb. 21, 2017

Progenra describes new USP7/USP47 inhibitors

Feb. 20, 2017

Toyama Chemical, Fujifilm identify novel C-X-C motif chemokine 10 inhibitors

Feb. 20, 2017

Allergan discloses new fMet-Leu-Phe/N-formyl peptide receptor 2 agonists

Feb. 17, 2017

Astellas Pharma describes novel MC4 receptor agonists

Feb. 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...